SCHEMBL8835972

SCHEMBL8835972

Fc1ccccc1-c1cnc2[nH]c3c(c2n1)CC1(CCCO1)CC3

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPKAPK2 P49137 8/20 0.37
▸ CYP2C9 P11712 1/20 0.33
▸ GABRA3 P34903 3/20 0.31
▸ GABRA2 P47869 2/20 0.31
▸ PLK4 O00444 1/20 0.31
▸ MAPK13 O15264 1/20 0.31
▸ DAPK3 O43293 1/20 0.31
▸ DYRK3 O43781 1/20 0.31
▸ RPS6KA4 O75676 1/20 0.31
▸ PRKD3 O94806 1/20 0.31
▸ MAP4K4 O95819 1/20 0.31
▸ CHEK2 O96017 1/20 0.31
▸ EGFR P00533 1/20 0.31
▸ CDK1 P06493 1/20 0.31
▸ MET P08581 1/20 0.31
▸ PIM1 P11309 1/20 0.31
▸ RPS6KB1 P23443 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ AXL P30530 1/20 0.31
▸ KDR P35968 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8836372 0.86 MAPKAPK2 (0.39) MAPKAPK2GABRA3GABRA2PLK4MAPK13
SCHEMBL8835509 0.86 MAPK1 (0.34) PIM1MAPK1KDR
SCHEMBL9045358 0.80 MAPKAPK2 (0.42) MAPKAPK2CYP2C9
SCHEMBL8835550 0.79 CUL4A (0.42) MAPKAPK2GABRA3GABRA2PLK4MAPK13
SCHEMBL8836316 0.78 MAPK1 (0.39) MAPKAPK2PIM1MAPK1KDR
SCHEMBL8835974 0.71 CRBN (0.32) MAPKAPK2CYP2C9
SCHEMBL9043057 0.69 HTR2C (0.34) GSK3A
SCHEMBL9042756 0.65 MAPKAPK2 (0.44) MAPKAPK2CSNK1DMAPK14
SCHEMBL8835838 0.64 NPC1 (0.46) CYP2C9MAPK1NPC1ALOX5APFEN1
SCHEMBL8922226 0.63 MAPK1 (0.42) MAPKAPK2PIM1MAPK1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5286860-A Certain aryl substituted pyrrolopyrazines; a new class of GABA brain receptor ligands NEUROGEN CORPORATION (US) 1994-02-15 — — US claimed
US-5668283-A Certain aryl substituted pyrrolopyrazines; a new class of GABA brain receptor ligands NEUROGEN CORPORATION (US) 1997-09-16 — — US disclosed
US-5606059-A USEFUL IN THE DIAGNOSIS AND TREATMENT OF ANXIETY, SLEEP AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE TYPE DRUGS AND THE ENHANCEMENT OF ALERTNESS NEUROGEN CORPORATION (US) 1997-02-25 — — US disclosed
US-5286860-A Certain aryl substituted pyrrolopyrazines; a new class of GABA brain receptor ligands NEUROGEN CORPORATION (US) 1994-02-15 — — US disclosed
Send feedback